The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of l-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's Disease
Stefan Schuster(Boehringer Ingelheim (Germany)), Erwan Bézard(Centre National de la Recherche Scientifique)
Cited by 87